Skip to main content
. 2019 Dec 30;14(12):e0227221. doi: 10.1371/journal.pone.0227221

Fig 2. Number of exacerbations 12 months prior to study inclusion and during 12 months’ study participation in subgroups with 0–1 and 2+exacerbations in the year prior to inclusion.

Fig 2

*p = 0.01 **p = 0.03.